HomeCompareQYLD vs ISRG

QYLD vs ISRG: Dividend Comparison 2026

QYLD yields 12.24% · ISRG yields 0.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 QYLD wins by $6.3K in total portfolio value· pulled ahead in Year 7
10 years
QYLD
Global X Nasdaq 100 Covered Call ETF
● Live price
12.24%
Share price
$16.70
Annual div
$2.04
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$6,038.84
Full QYLD calculator →
ISRG
ISRG
● Live price
0.44%
Share price
$452.78
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.3K
Annual income
$45.46
Full ISRG calculator →

Portfolio growth — QYLD vs ISRG

📍 QYLD pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodQYLDISRG
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, QYLD + ISRG cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
QYLD pays
ISRG pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QYLD
Annual income on $10K today (after 15% tax)
$1,040.82/yr
After 10yr DRIP, annual income (after tax)
$5,133.01/yr
ISRG
Annual income on $10K today (after 15% tax)
$37.55/yr
After 10yr DRIP, annual income (after tax)
$38.64/yr
At 15% tax rate, QYLD beats the other by $5,094.37/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QYLD + ISRG for your $10,000?

QYLD: 50%ISRG: 50%
100% ISRG50/50100% QYLD
Portfolio after 10yr
$23.4K
Annual income
$3,042.15/yr
Blended yield
12.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ISRG right now

QYLD
No analyst data
ISRG
Analyst Ratings
37
Buy
12
Hold
5
Sell
Consensus: Buy
Price Target
$638.75
+41.1% upside vs current
Range: $550.00 — $750.00
Altman Z
37.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QYLD buys
1
ISRG buys
0
PoliticianChamberTickerTypeAmountDate
Tim Moore🏢 House$QYLD▼ Sell$15,001 - $50,0002025-05-02
Tim Moore🏢 House$QYLD▲ Buy$15,001 - $50,0002025-04-07
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002022-11-14
Dwight Evans🏢 House$QYLD▼ Sell$1,001 - $15,0002020-10-29
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricQYLDISRG
Forward yield12.24%0.44%
Annual dividend / share$2.04$2.00
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$26.5K$20.3K
Annual income after 10y$6,038.84$45.46
Total dividends collected$28.5K$449.00
Payment frequencymonthlyquarterly
SectorETFStock

Year-by-year: QYLD vs ISRG ($10,000, DRIP)

YearQYLD PortfolioQYLD Income/yrISRG PortfolioISRG Income/yrGap
1$10,384$1,224.49$10,744$44.17$360.00ISRG
2$10,900$1,388.18$11,541$44.35$641.00ISRG
3$11,576$1,590.76$12,393$44.53$817.00ISRG
4$12,447$1,844.20$13,305$44.69$858.00ISRG
5$13,567$2,164.97$14,281$44.84$714.00ISRG
6$15,003$2,576.05$15,326$44.98$323.00ISRG
7← crossover$16,853$3,110.04$16,444$45.11+$409.00QYLD
8$19,251$3,813.85$17,640$45.23+$1.6KQYLD
9$22,390$4,756.08$18,920$45.35+$3.5KQYLD
10$26,548$6,038.84$20,290$45.46+$6.3KQYLD

QYLD vs ISRG: Complete Analysis 2026

QYLDETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

ISRGStock

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Full ISRG Calculator →
📬

Get this QYLD vs ISRG comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QYLD vs XYLDQYLD vs JEPIQYLD vs JEPQQYLD vs RYLDQYLD vs QYLGQYLD vs SCHDQYLD vs OQYLD vs KO

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.